These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28611272)

  • 21. HBsAg seroclearance in chronic hepatitis B: implications for hepatocellular carcinoma.
    Kim JH; Lee YS; Lee HJ; Yoon E; Jung YK; Jong ES; Lee BJ; Seo YS; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
    J Clin Gastroenterol; 2011 Jan; 45(1):64-8. PubMed ID: 20535028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of chronic hepatitis B in severe liver disease.
    Fung J; Lai CL; Yuen MF
    World J Gastroenterol; 2014 Nov; 20(43):16053-61. PubMed ID: 25473157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.
    Safaie P; Poongkunran M; Kuang PP; Javaid A; Jacobs C; Pohlmann R; Nasser I; Lau DT
    World J Gastroenterol; 2016 Mar; 22(12):3404-11. PubMed ID: 27022222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.
    Paik N; Sinn DH; Lee JH; Oh IS; Kim JH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Liver Int; 2018 Jan; 38(1):68-75. PubMed ID: 28581248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years.
    Buti M; Fung S; Gane E; Afdhal NH; Flisiak R; Gurel S; Flaherty JF; Martins EB; Yee LJ; Dinh P; Bornstein JD; Mani Subramanian G; Janssen HL; George J; Marcellin P
    Hepatol Int; 2015 Apr; 9(2):243-50. PubMed ID: 25788199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progression to cirrhosis, hepatocellular carcinoma and liver-related mortality in chronic hepatitis B patients in Italy.
    Ieluzzi D; Covolo L; Donato F; Fattovich G
    Dig Liver Dis; 2014 May; 46(5):427-32. PubMed ID: 24548819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between quantitative serum HBsAg and HBV DNA test in Korean patients who showed high level of HBsAg.
    Lee JH; Kim SJ; Ahn SH; Lee J; Park Y; Kim HS
    J Clin Pathol; 2010 Nov; 63(11):1027-31. PubMed ID: 20870658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for hepatocellular carcinoma after HBsAg clearance age before cirrhosis?: age before cirrhosis?
    Lutchman GA; Nguyen MA
    J Clin Gastroenterol; 2011 Jan; 45(1):4-5. PubMed ID: 21063212
    [No Abstract]   [Full Text] [Related]  

  • 29. Association between mitochondrial DNA content and baseline serum levels of HBsAg in chronic hepatitis B infection.
    Chen T; Xun Z; Lin J; Fu Y; Wu W; Fu X; Hu Y; Zeng Y; Ou Q
    J Med Virol; 2017 Nov; 89(11):1958-1962. PubMed ID: 28657148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma in Korea.
    Park BC; Han BH; Ahn SY; Lee SW; Lee DH; Lee YN; Seo JH; Kim KW
    J Viral Hepat; 1995; 2(4):195-202. PubMed ID: 7489347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: an analysis of clinical studies.
    Değertekin H; Yalçin K; Yakut M
    Turk J Gastroenterol; 2006 Mar; 17(1):25-34. PubMed ID: 16830274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Hosaka T; Sezaki H; Kobayashi M; Kumada H
    Am J Med; 2006 Jan; 119(1):71.e9-16. PubMed ID: 16431195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy.
    Lin TC; Chiu YC; Chiu HC; Liu WC; Cheng PN; Chen CY; Chang TT; Wu IC
    World J Gastroenterol; 2018 Feb; 24(6):725-736. PubMed ID: 29456411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term natural history of liver disease in patients with chronic hepatitis B virus infection: an analysis using the Markov chain model.
    Tada T; Kumada T; Toyoda H; Ohisa M; Akita T; Tanaka J
    J Gastroenterol; 2018 Nov; 53(11):1196-1205. PubMed ID: 29675604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.
    El-Maksoud MA; Habeeb MR; Ghazy HF; Nomir MM; Elalfy H; Abed S; Zaki MES
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):716-722. PubMed ID: 30870221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
    Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history of chronic hepatitis B: what exactly has REVEAL revealed?
    Iloeje UH; Yang HI; Chen CJ
    Liver Int; 2012 Oct; 32(9):1333-41. PubMed ID: 22510145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of chronic hepatitis B infection.
    Sundaram V; Kowdley K
    BMJ; 2015 Oct; 351():h4263. PubMed ID: 26491030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.